Propanc Biopharma Inc. (PPCB)
NASDAQ: PPCBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 0.4804 -3.67%
PPCB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $4.90M
- EPS (TTM)
- -$17.62
- Dividend yield
- None
- 52-week range
- 0.46 – 49.25
- Day range
- 0.46 – 0.5071
- Volume / Avg
- 860.44K / 1.78M
- Beta
- —
- Shares outstanding
- 9.83M
52-week range
PPCB stock today
On Oct 7, PPCB ended the session at $0.4987, adding $0.0074 (1.51%), versus the S&P 500's 0.22% decline. Trading was light, with 860.44K shares changing hands, about 48% of the average daily volume. Shares are 99.0% below their 52-week high of $49.25 and 8.4% above the 52-week low of $0.46, near the bottom of the past year's range.
Propanc Biopharma has posted a net loss over the last twelve months (EPS of -$17.62), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Propanc Biopharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Propanc Biopharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XTLBXTL Biopharmaceuticals Ltd. ADR | 1.98 | -1.98% | $4.87M | vs PPCB |
| NCNANuCana plc ADR | 1.14 | +4.59% | $4.74M | vs PPCB |
| LNAILunai Bioworks Inc. | 1.09 | -3.54% | $4.94M | vs PPCB |
| XBIOXenetic Biosciences Inc. | 2.21 | +2.55% | $5.18M | vs PPCB |
| PULMPulmatrix Inc. | 1.49 | +4.20% | $5.44M | vs PPCB |
| RDHLRedhill Biopharma Ltd. ADR | 0.474 | -2.07% | $4.21M | vs PPCB |
| ADXNAddex Therapeutics Ltd ADR | 3.13 | -0.32% | $5.49M | vs PPCB |
| DRMADermata Therapeutics Inc. | 1.12 | -0.89% | $5.55M | vs PPCB |
Indexes, lists and sector
Propanc Biopharma stock FAQ
What is Propanc Biopharma's stock price today?
PPCB last traded at $0.4987 as of Oct 7, 4:00 PM EDT, up 1.51% on the day. Prices are delayed at least 15 minutes.
What is the PPCB 52-week high?
The 52-week high for PPCB is $49.25 and the 52-week low is $0.46. The stock is currently 99.0% below its high.